BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 31192957)

  • 1. High mobility group box 1 mediates inflammatory responses in malignant peritoneal mesothelioma.
    Wang L; Wang X; Sun N; Liu W
    Int Immunopharmacol; 2024 May; 133():112039. PubMed ID: 38613884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled Breath Analysis in Diagnosis of Malignant Pleural Mesothelioma: Systematic Review.
    Töreyin ZN; Ghosh M; Göksel Ö; Göksel T; Godderis L
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32050546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
    Lagniau S; Lamote K; van Meerbeeck JP; Vermaelen KY
    Oncotarget; 2017 Aug; 8(32):53751-53762. PubMed ID: 28881848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic reviews of diagnostic test accuracy for evidence-based diagnostic practice in Africa.
    Ochodo EA; Leeflang MMG
    Afr J Lab Med; 2012; 1(1):7. PubMed ID: 29062727
    [No Abstract]   [Full Text] [Related]  

  • 5. CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.
    Cortes-Dericks L; Schmid RA
    Respir Res; 2017 Apr; 18(1):58. PubMed ID: 28403901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.
    Liu H; Wu L; Ji K; Wang W
    Tumour Biol; 2015 Sep; 36(10):7375-84. PubMed ID: 26361957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for detecting malignant pleural mesothelioma: Protocol for a reanalysis of published data based on systematic reviews of diagnostic test accuracy.
    Zan X; Wang Y; Shi J; Zhao L; Zhao Y; Liu R; Zhou Y; Wan Y;
    Medicine (Baltimore); 2019 Jun; 98(24):e16028. PubMed ID: 31192957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of biomarkers in colorectal cancer: Protocol for an overview and a secondary analysis of systematic reviews of diagnostic test accuracy.
    Wang J; Liang W; Wang X; Min G; Chen W; Wang H; Yao N; Wang J;
    Medicine (Baltimore); 2019 Jun; 98(24):e16034. PubMed ID: 31192959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for detecting prostate cancer: Protocol for an umbrella review with integrated network meta-analysis.
    Jia J; Sun Y; Ren J; Li M; Wang J; Li H;
    Medicine (Baltimore); 2019 Jul; 98(30):e16517. PubMed ID: 31348264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview protocol of biomarkers for breast cancer detection.
    Sheng Z; Wang J; Li M; Luo X; Cai R; Zhang M;
    Medicine (Baltimore); 2019 Jun; 98(24):e16024. PubMed ID: 31192953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma: An updated meta-analysis.
    Gao R; Wang F; Wang Z; Wu Y; Xu L; Qin Y; Shi H; Tong Z
    Medicine (Baltimore); 2019 Apr; 98(14):e14979. PubMed ID: 30946324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of biomarkers for ovarian cancer: Protocol for an overview, evidence mapping, and adjusted indirect comparisons.
    Hua J; Liu J; Hua M; Cai R; Li M; Wang J; Wang J;
    Medicine (Baltimore); 2019 May; 98(18):e15508. PubMed ID: 31045839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of four imaging modalities in diagnosing lymph node involvement in rectal cancer: an overview and adjusted indirect comparison.
    Gao Y; Li J; Ma X; Wang J; Wang B; Tian J; Chen G
    Clin Exp Med; 2019 May; 19(2):225-234. PubMed ID: 30900099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The methodological quality of robotic surgical meta-analyses needed to be improved: a cross-sectional study.
    Yan P; Yao L; Li H; Zhang M; Xun Y; Li M; Cai H; Lu C; Hu L; Guo T; Liu R; Yang K
    J Clin Epidemiol; 2019 May; 109():20-29. PubMed ID: 30579979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review.
    Bruno R; Alì G; Fontanini G
    J Thorac Dis; 2018 Jan; 10(Suppl 2):S342-S352. PubMed ID: 29507804
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.